Marker Therapeutics (MRKR) Q2 2026 Earnings

20MayConfirmed
Q3 2025
Q4 2025
Next
Next
-0.36
-0.28
-0.2
-0.12

Details

Expected EPS
-0.20575
Actual EPS
N/A
Surprise EPS
0.21
Surprise Percent
+100%

Description

Marker Therapeutics (MRKR) will report earnings of for Q2 2026 on May 20, 2026.

0 Comments

Share your thoughts